Elios Vision
Cavan Farley is an accomplished biotech executive with over 20 years of experience in leadership roles at global pharmaceutical companies. Currently, Farley serves as the Vice President, Payor Accounts at Elios Vision and as President at Brightspan Consulting, LLC, where the focus is on developing unique strategies to enhance pharma/biotech core capabilities. In previous roles at companies like Gilead Sciences, Allergan, and GlaxoSmithKline, Farley has demonstrated expertise in market access, corporate strategy, and business development. Farley holds a BA in PreMed, Journalism, and Business from the University of Richmond.
Elios Vision
ELIOS is a microinvasive, implant-free procedure that uses excimer laser light energy to create microscopic openings in the trabecular meshwork to re-establish the natural flow of eye fluid, or aqueous.